Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules
Dhillon VK, Sistrunk JW, Hughes DT, Beninato T, Chablani S, Tufano RP, Baldwin CK. North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Benign Non-functional Thyroid Nodules. Endocr Pract. 2026 May 12:S1530-891X(26)00969-9. doi: 10.1016/j.eprac.2026.05.002. Epub ahead of print. PMID: 42119976.

Ablative Therapy for the Management of Low Risk Papillary Thyroid Carcinoma
Baldwin CK, Frazier KM, Kuo JH, Noel JE, Russell JO, Banuchi VE. North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Low Risk Papillary Thyroid Carcinoma. Endocr Pract. 2026 Jun 26:S1530-891X(26)01030-X. doi: 10.1016/j.eprac.2026.05.037. Epub ahead of print. PMID: 42362053.

Ablative Therapy for the Management of Cervical Recurrence of Papillary Thyroid Cancer
Dueñas JP, Buitrago-Gómez N, Goldenberg D, Abraham D, Park BJ, Lim J, Spiezia S, Rangel LG, Cunnane ME. North American Society for Interventional Thyroidology Statement on Directed Ablative Therapy for the Management of Cervical Recurrence of Papillary Thyroid Cancer. Endocr Pract. 2026 Jul 4:S1530-891X(26)01044-X. doi: 10.1016/j.eprac.2026.06.009. Epub ahead of print. PMID: 42401202.